# M/s. Shree Dhanvantari Pharmaceuticals vs. M/s. Konkan Ayur Pharma Private Limited

> NCLAT judgment dated 2026-07-17. Citation: TCN-2026-NCLAT-00221. M/s. Shree Dhanvantari Pharmaceuticals (Appellant), a partnership firm, filed a Section 7 IBC…

- **Court:** NCLAT
- **Order date:** 17 Jul 2026
- **Citation:** TCN-2026-NCLAT-00221
- **Category:** IBC
- **Source page:** https://caseease.in/cases/ibc/nclat-new-delhi/ms-shree-dhanvantari-pharmaceuticals-vs-ms-konkan-ayur-pharma-private-limited-dnavr

## Summary

### Background

M/s. Shree Dhanvantari Pharmaceuticals (Appellant), a partnership firm, filed a Section 7 IBC application against M/s. Konkan Ayur Pharma Private Limited (Corporate Debtor) for unpaid loans totaling ₹.2,26,45,568/- (plus interest). The Adjudicating Authority dismissed the application citing lack of clarity on the date of default, absence of material, want of proper authority, and partner disputes within the appellant firm. The present appeal challenges this dismissal.

## Facts

The Appellant, M/s. Shree Dhanvantari Pharmaceuticals, is a partnership firm engaged in the development, manufacture, and trading of Ayurvedic medicines.

The Corporate Debtor, M/s. Konkan Ayur Pharma Private Limited, was incorporated on 27.08.2008 under an AYUSH cluster initiative.

The Appellant claims to have advanced loans totaling ₹.2,26,45,568/- to the Corporate Debtor, which remained unpaid.

With 18% interest per annum, a sum of ₹.3,55,54,900/- became due and payable.

On 14.05.2022, the Appellant issued a demand notice to the Corporate Debtor for repayment.

Upon the Corporate Debtor's failure to repay, the Appellant filed a petition under Section 7 of the IBC for initiating CIRP.

…

## Issues and analysis

### Issue 1: Whether the Adjudicating Authority overstepped the scope of enquiry by examining issues beyond the …

**Ratio:** The Adjudicating Authority's primary role under Section 7 of the IBC is to ascertain the

…

**Reasoning:** The NCLAT acknowledged that while the core inquiry is debt and default, the question of

…

**Interpretation:** The scope of inquiry under Section 7, while focused on debt and default,

…

**Application:** The Adjudicating Authority was justified in examining the authority of the

…

## Parties

- **Judges:** N. Sesha…; Arun Ba…
- **Appellants:** M/s. Shree…
- **Respondents:** M/s. Konkan Ayur…; Respondent…; +2 more
- **Other parties:** Nandkishore…
- **Advocates:** Gaurav…; PCS Alpa…; +4 more

## Timeline

- **1992-07-14 — Partnership Firm…**: The petitioner/appellant partnership firm came…
- **2008-08-27 — Corporate Debtor…**: The Corporate Debtor was incorporated…

## Legal provisions

- [Insolvency and Bankruptcy Code, 2016, Section 7 — Initiation of corporate insolvency resolution…](https://caseease.in/legal-provisions/insolvency-and-bankruptcy-code-2016/section-7)

---

This is a preview. The full structured summary, issues, precedents and source judgment are available on CaseEase - Legal Intelligence Simplified: https://caseease.in/cases/ibc/nclat-new-delhi/ms-shree-dhanvantari-pharmaceuticals-vs-ms-konkan-ayur-pharma-private-limited-dnavr